Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 5Tumor-Agnostic 4Thoracic 4Genitourinary 3Gastrointestinal 3Other hematologic neoplasm 2Gynecologic 2Lymphoid 1Dermatologic 1CNS 1

Conditions

Neoplasms 4

Interventions

pembrolizumab 56Specimen Handling 28Biopsy 27Magnetic Resonance Spectroscopy 26Paclitaxel 22Blood Specimen Collection 21Nivolumab 20atezolizumab 18Standard of Care 18Carboplatin 18Surveys and Questionnaires 17Bevacizumab 17Oxaliplatin 13Fluorouracil 13Cisplatin 13Radiotherapy 12Radiosurgery 12Cyclophosphamide 12Pemetrexed 11Leucovorin 11Irinotecan 10Gemcitabine 10Docetaxel 10Capecitabine 10trastuzumab deruxtecan 8olaparib 8Taxes 8Ipilimumab 8durvalumab 7Trastuzumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Focus Groups × Tumor-Agnostic × 1 year × Clear all
NCT06549153 2026-03-09

ACT-Together (Acting on Cancer Testing-Together)

M.D. Anderson Cancer Center

Phase NA Active not recruiting
30 enrolled
Tumor-Agnostic

Neoplasms

NCT00832325 2026-03-03

Adolescent and Young Adult Cancer Survivors: Identity Development

Memorial Sloan Kettering Cancer Center

Active not recruiting
300 enrolled
Tumor-Agnostic

Neoplasms

NCT05694650 2026-03-03

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

M.D. Anderson Cancer Center

Recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

NCT07105046 2026-03-02

Facilitators and Barriers to Cancer Treatment Among Texas Residents

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡